Evidence map›Paper›PMID 41869372›Full record

ArticleTobacco prevention & cessation2026

Clinical and psychosocial factors predicting persistent smoking in hospitalized patients with atherosclerotic vascular disease: A prespecified analysis of two randomized controlled trials.

Vilde Getz, Karin Pleym, Toril Dammen, Einar Husebye, Elise Sverre, Costas Papageorgiou, Harald Weedon-Fekjær, John Munkhaugen

2 registry-linked trialsAbstract read
In one paragraph

Article in Tobacco prevention & cessation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04772144 nacompletednot on this map

Smoking Cessation After a Cardiovascular Disease Event With Hospital-based Nurse-coordination and Further Follow-up Care in Lifestyle Centres With Free Cessation Aids - an Interdisciplinary Randomized Pilot Study

TypeinterventionalSponsorVestre Viken Hospital TrustRan2021 to 2022Enrolled58ConditionsSmoking Cessation, Smoking Behaviors, Nurse's Role, Cardiovascular DiseasesArmsbehavioural and cessation aids
NCT05049174 naactive not recruitingnot on this map

Clinical and Health-economic Effects of a Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres With Free Cessation Drugs: a Randomized Clinical Trial

TypeinterventionalSponsorVestre Viken Hospital TrustRan2021 to 2026Enrolled221ConditionsSmoking Cessation, Smoking Behaviors, Nurse's Role, Cardiovascular DiseasesArmsNuse-led interview and referral to municipal healthy life-centres
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vilde GetzDepartment of Medicine, Drammen Hospital, Drammen, Norway.
Karin PleymDepartment of Medicine, Drammen Hospital, Drammen, Norway.
Toril DammenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Einar HusebyeDepartment of Medicine, Drammen Hospital, Drammen, Norway.
Elise SverreDepartment of Medicine, Drammen Hospital, Drammen, Norway.
Costas PapageorgiouDepartment of Psychology, University of Oslo, Oslo, Norway.
Harald Weedon-FekjærOslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
John MunkhaugenDepartment of Medicine, Drammen Hospital, Drammen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSmoking remains prevalent after hospitalization for atherosclerotic vascular disease, even with cessation programs. Understanding the clinical and psychosocial factors influencing long-term abstinence is essential for identifying patients who may benefit from tailored interventions. This study aimed to identify clinical and psychosocial factors associated with sustained smoking cessation in patients with atherosclerotic disease who were admitted to hospital for an elective or unplanned vascular event and enrolled in a cessation intervention study.

methodsThis is a prespecified analysis of two randomized intervention trials that recruited participants from three secondary care hospitals in Norway between 2021 and 2023. Patients who smoked at least one cigarette daily before admission were randomized to: 1) motivational counselling and proactive referral to municipal cessation services (intervention); or 2) brief advice and contact information (control). Data were collected from medical records, a questionnaire, and telephone interviews. Logistic regression analyses were used to identify the prespecified factors associated with smoking status at 12 months.

resultsIn the total study population (n=262), 34% (n=88) reported 12-month sustained smoking abstinence. Anxiety diagnosis (adjusted odds ratio, AOR=4.2), shorter sleep duration per hour (AOR=1.3), living alone (AOR=2.2), somatic comorbidity per point on the Charlson score (AOR=1.5), and being in the precontemplation stage (AOR=2.9) were associated with persistent smoking. Increasing motivation per point on a 0-10 Likert scale (AOR=0.7), being in the preparation stage (AOR=0.4), and myocardial infarction or stroke as the index diagnosis (AOR=0.5) were associated with smoking abstinence. Results were generally consistent across intervention allocation groups.

conclusionsMotivation and readiness for smoking cessation were key predictors of abstinence. Living alone, anxiety disorders, and shorter sleep duration were associated with persistent smoking. These factors may help identify subgroups who could benefit from more targeted support. CLINICAL

trial registrationThe study is registered on the official website of ClinicalTrials.gov. IDENTIFIERS: NCT04772144 and NCT05049174.

Indexed as

atherosclerotic vascular diseaseclinical and psychosocial factorssecondary preventionsmoking cessation

Identifiers

PMID41869372
PMCPMC13001752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.